MPT facilitates the release of mitochondrial intermembrane proteins, including endonuclease G and apoptosis-inducing factor, both of which translocate to the nucleus
Specifically, those with plasma homocysteine levels greater than 14 mol/L had nearly double the risk of developing Alzheimer's disease (71)
PubMed, 2024 Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults British Journal of Pharmacology, 2025 Consuming more protein may protect patients taking an anti-obesity drug from muscle loss Endocrine Society, ENDO 2025 Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss Mass General Advances in Motion GLP-1s and Lean Mass: What the Research Shows ACE Certified, June 2025 New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation American Diabetes Association, 2025 Impact of GLP-1 Receptor Agonist Therapy in Patients at High Risk for Sarcopenia Current Nutrition Reports, Springer, 2025
It's necessary to consult with a healthcare professional before starting sermorelin therapy, especially for individuals with certain medical conditions or those taking specific medications
Direct answer: Risk may rise in people with existing gastroparesis, diabetes-related nerve damage, prior gastrointestinal surgery, severe constipation, dehydration, or other medicines that slow digestion
